Klinger Shannon Thyme

Track

Insider profile

Performance

Overall performance
4.1
Performance over holding periods
4.1
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 71% 68% 82%
Transactions
25 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Klinger Shannon Thyme's trades of Moderna Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-04 2026-06-04
US Moderna Inc (MRNA)
PrS Proposed sale
52,038
354.07
US$3,505,600 		52,038 354.07 US$3,505,600
2026-03-03 2026-03-02
US Moderna Inc (MRNA)
PlS Planned sale
59,152 +46.2%
381.48
US$3,864,043 		59,152 +46.2% 381.48 US$3,864,043
2026-03-02 2026-03-02
US Moderna Inc (MRNA)
PrS Proposed sale
23,876
345.64
US$2,670,652 		23,876 345.64 US$2,670,652
2024-12-10 2024-12-09
US Moderna Inc (MRNA)
S Sale
529 -2.5%
44.68
US$23,637 		529 -2.5% 44.68 US$23,637
2024-12-09 2024-12-09
US Moderna Inc (MRNA)
PrS Proposed sale
529
44.68
US$23,637 		529 44.68 US$23,637
2024-12-04 2024-12-03
US Moderna Inc (MRNA)
S Sale
112 -0.6%
43.30
US$4,849 		112 -0.6% 43.30 US$4,849
2024-12-03 2024-12-03
US Moderna Inc (MRNA)
PrS Proposed sale
112
43.30
US$4,849 		112 43.30 US$4,849
2024-12-02 2024-11-29
US Moderna Inc (MRNA)
S Sale
1,418 -6.7%
42.79
US$60,675 		1,418 -6.7% 42.79 US$60,675
2024-11-29 2024-11-29
US Moderna Inc (MRNA)
PrS Proposed sale
1,418
42.79
US$60,675 		1,418 42.79 US$60,675
2024-09-10 2024-09-09
US Moderna Inc (MRNA)
S Sale
551 -2.9%
73.57
US$40,539 		551 -2.9% 73.57 US$40,539
2024-09-09 2024-09-09
US Moderna Inc (MRNA)
PrS Proposed sale
551
73.57
US$40,539 		551 73.57 US$40,539
2024-09-04 2024-09-03
US Moderna Inc (MRNA)
S Sale
114 -0.6%
76.99
US$8,777 		114 -0.6% 76.99 US$8,777
2024-09-03 2024-09-03
US Moderna Inc (MRNA)
PrS Proposed sale
114
76.99
US$8,777 		114 76.99 US$8,777
2024-08-30 2024-08-29
US Moderna Inc (MRNA)
S Sale
162 -0.9%
78.03
US$12,640 		162 -0.9% 78.03 US$12,640
2024-08-29 2024-08-29
US Moderna Inc (MRNA)
PrS Proposed sale
162
78.03
US$12,640 		162 78.03 US$12,640
2024-08-29 2024-08-28
US Moderna Inc (MRNA)
S Sale
1,319 -7.1%
79.39
US$104,722 		1,319 -7.1% 79.39 US$104,722
2024-08-28 2024-08-28
US Moderna Inc (MRNA)
PrS Proposed sale
1,319
79.39
US$104,722 		1,319 79.39 US$104,722
2024-06-11 2024-06-10
US Moderna Inc (MRNA)
S Sale
5,178 -24.5%
148.09
US$766,785 		5,178 -24.5% 148.09 US$766,785
2024-06-10 2024-06-10
US Moderna Inc (MRNA)
PrS Proposed sale
5,178
148.09
US$766,785 		5,178 148.09 US$766,785
2024-06-04 2024-06-03
US Moderna Inc (MRNA)
S Sale
122 -1.1%
140.72
US$17,168 		122 -1.1% 140.72 US$17,168
2024-06-03 2024-06-03
US Moderna Inc (MRNA)
PrS Proposed sale
122
140.72
US$17,168 		122 140.72 US$17,168
2024-05-30 2024-05-29
US Moderna Inc (MRNA)
S Sale
183 -1.7%
144.50
US$26,444 		183 -1.7% 144.50 US$26,444
2024-05-29 2024-05-29
US Moderna Inc (MRNA)
PrS Proposed sale
183
144.50
US$26,444 		183 144.50 US$26,444
2024-05-29 2024-05-28
US Moderna Inc (MRNA)
S Sale
1,296 -10.9%
162.47
US$210,566 		1,296 -10.9% 162.47 US$210,566
2024-05-28 2024-05-28
US Moderna Inc (MRNA)
PrS Proposed sale
1,296
162.47
US$210,566 		1,296 162.47 US$210,566
2024-03-11 2024-03-08
US Moderna Inc (MRNA)
S Sale
544 -5.5%
99.05
US$53,884 		544 -5.5% 99.05 US$53,884
2024-03-08 2024-03-08
US Moderna Inc (MRNA)
PrS Proposed sale
544
99.05
US$53,884 		544 99.05 US$53,884
2024-03-05 2024-03-04
US Moderna Inc (MRNA)
S Sale
117 -1.3%
94.34
US$11,038 		117 -1.3% 94.34 US$11,038
2024-03-04 2024-03-04
US Moderna Inc (MRNA)
PrS Proposed sale
117
94.34
US$11,038 		117 94.34 US$11,038
2024-03-01 2024-02-29
US Moderna Inc (MRNA)
S Sale
670 -7.3%
94.57
US$63,363 		670 -7.3% 94.57 US$63,363
2024-02-29 2024-02-29
US Moderna Inc (MRNA)
PrS Proposed sale
670
94.57
US$63,363 		670 94.57 US$63,363
2023-12-11 2023-12-08
US Moderna Inc (MRNA)
S Sale
563 -6.6%
79.09
US$44,525 		563 -6.6% 79.09 US$44,525
2023-12-08 2023-12-08
US Moderna Inc (MRNA)
PrS Proposed sale
563
79.09
US$44,525 		563 79.09 US$44,525
2023-12-05 2023-12-04
US Moderna Inc (MRNA)
S Sale
111 -1.5%
79.31
US$8,804 		111 -1.5% 79.31 US$8,804
2023-12-04 2023-12-04
US Moderna Inc (MRNA)
PrS Proposed sale
111
79.31
US$8,804 		111 79.31 US$8,804
2023-09-11 2023-09-08
US Moderna Inc (MRNA)
S Sale
557 -7.2%
107.22
US$59,722 		557 -7.2% 107.22 US$59,722
2023-09-08 2023-09-08
US Moderna Inc (MRNA)
PrS Proposed sale
557
107.22
US$59,722 		557 107.22 US$59,722
2023-09-06 2023-09-05
US Moderna Inc (MRNA)
S Sale
115 -1.7%
111.44
US$12,815 		115 -1.7% 111.44 US$12,815
2023-09-05 2023-09-05
US Moderna Inc (MRNA)
PrS Proposed sale
115
111.44
US$12,815 		115 111.44 US$12,815
2023-06-09 2023-06-08
US Moderna Inc (MRNA)
S Sale
565 -8.0%
124.09
US$70,111 		565 -8.0% 124.09 US$70,111
2023-06-08 2023-06-08
US Moderna Inc (MRNA)
PrS Proposed sale
565
124.09
US$70,111 		565 124.09 US$70,111
2023-06-05 2023-06-02
US Moderna Inc (MRNA)
S Sale
110 -1.8%
130.32
US$14,336 		110 -1.8% 130.32 US$14,336
2023-06-02 2023-06-02
US Moderna Inc (MRNA)
PrS Proposed sale
110
130.32
US$14,336 		110 130.32 US$14,336
2023-03-09 2023-03-08
US Moderna Inc (MRNA)
S Sale
561 -8.8%
141.51
US$79,388 		561 -8.8% 141.51 US$79,388
2023-03-03 2023-03-02
US Moderna Inc (MRNA)
S Sale
459 -8.0%
136.43
US$62,623 		459 -8.0% 136.43 US$62,623